NAICS Code: 325412

Period of Performance: 04/01/2013 to 03/31/2014

The statutory authority permitting other than full and open competition is 41 U.S.C. 253(c)(1) as cited in FAR 13.106-1(b)(1)(i). CDC's Advisory Committee for Immunization Practices recommends that all children receive the DTaP series for protection against diphtheria, tetanus, and pertussis. Currently, there are two vaccine manufacturers licensed to produce DTaP-containing vaccines in the US, GlaxoSmithKline (GSK) and Sanofi Pasteur. Sanofi is not able to provide the needed vaccines so they need to be purchased from GSK and in order to do this, the maximum dosage quantities need to be increased for these three vaccines.

Responsible sources that believe they possess the expertise and capabilities identified above are encouraged to submit to the Contracting Officer within 15 days from the posting date of this notice, their written capabilities statement, proposal or quotation which shall be considered by the agency for future procurement. Please forward the capability statement and/or pricing information to Michael Harwell, Contracting Specialist, Reference 200-2013-54509, Centers for Disease Control, Procurement and Grants Office, ATTN: Michael Harwell, MS: K14, 2920 Brandywine Road, Atlanta, GA 30341. All vendors must be registered in the System for Award Management (SAM) prior to an award of a federal contract. The website is: www.sam.gov.

This is a posting of a sole source award to GlaxoSmithKline and is not a request for competition.